Searched for
CEPHALON
Lupin rallies on USFDA approval for generic drugAt 09:40 am, Lupin shares were trading 1.06 per cent higher at 1,533. They hit a low of Rs 1,526 and a high of Rs 1,545 in the first 30 min...- Lupin receives USFDA approval for generic drug to treat sleep disordersLupin's share prices rose 0.82% on Tuesday to close at Rs1,517.05 on BSE, where the benchmark Sensex ended 0.17% higher.
- Natco Pharma gets USFDA nod for Armodafinil tabletsNatco Pharma has received final approval from the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets.
- Glenmark Pharmaceuticals gets two ANDA approvals from USFDAGlenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment inje...
- Natco Pharma's US partner gets FDA nod for wakefulness tabletsBreckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.
- Glenmark faces patent infringement suit in USGlenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc to sell generic version of Treanda.
- Lupin gets US nod for Armodafinil tablets, Doxycycline capsulesDrug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsule...
- Aurobindo Pharma gets USFDA nod for Modafinil tablets"The company has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Modafinil tablets USP 100mg and...
- Jeremy Levin named as next CEO of Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries Ltd named Jeremy Levin of Bristol-Myers Squibb Coto to replace Shlomo Yanai as chief executive officer.
- Teva to buy Taiyo stake for $460 million, bid for restTeva Pharmaceutical Industries Ltd agreed to buy 57% of Taiyo Pharmaceutical Industry Co Ltd. for $460 million and bid for the rest.
- Technology M&As may cost speculators more than $1 bnLawson Software's agreement to sell itself for about $1.9 billion wiped out $175 million for investors who had speculated a higher offer wa...
- Teva to buy Ratiopharm for nearly $5 bnIsrael's Teva has won the battle for German generic drugmaker Ratiopharm, paying an enterprise value of 3.63 billion euros to fix its weakn...
- Are your drugs boosting your doctor's lifestyle?If you knew your doctor was a contestant for these prizes, how confident would you feel that what has been prescribed to you is what you ne...
- Children's disorders increases sales of US pharma cosSales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...
- Plavix Accord: Bristol-Myers, Sanofi face criminal probeSanofi-Aventis said the US started a criminal probe of a plan to keep a generic version of their top-selling blood-thinner Plavix off the m...
Load More
